News

PrecisionLife Licenses University of Oxford Data to Discover Personalised Treatments for Endometriosis Patients

- PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis and identify novel drug targets to support the development of new personalised treatments for millions of women worldwide.


Oxford, UK, 29 June 2023 – PrecisionLife, a leading techbio company driving precision medicine in complex chronic diseases, announced today a data access agreement with the University of Oxford to license the Oxford Endometriosis Gene (OXEGENE) dataset with the aim to develop new personalised treatments for endometriosis patients.

Read more

Kadans Science Partner has submitted its application for a new purpose-built R&D building

Planning Submitted at 4 Brandon Road, Kings Cross


Designed collaboratively with the Kadans in-house team and DMA, the building sits adjacent to the existing 5-10 Brandon Road to provide a range of complimentary spaces. 


The proposal at 4 Brandon Road is five storeys of flexible lab space with the addition of basement and roof plant. Designed with adaptability at the core, the floorplates are arranged on a regular grid to minimise vibration and maximise usable space.  

Read more

Advancing Clinical Trials with iPSC-Derived Liver Organoids

AMSBIO has published a blog about Dr. Satoshi Okamoto’s groundbreaking research on the production of induced pluripotent stem cells (iPSC)-derived liver organoids, and their significant potential in clinical research trials.

Read more

Final Call for ON Helix 2023!

Don't miss ON Helix 2023 - details here!


Read more

ARECOR GRANTED KEY PATENTS IN EUROPE AND CHINA TO PROTECT PROPRIETARY INSULIN PRODUCTS

Patents further strengthen Group’s extensive patent portfolio protecting its Arestat™ technology and innovative insulin products, AT278 and AT247

Read more

Alchemab Unveils Alzheimer's Candidate ATLX-1088 Targeting CD33 at the Antibody Industrial Symposium 2023

Cambridge, UK, June 22, 2023 – Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to disease, today announced that it un

Read more

ARECOR PRESENTS POSITIVE DATA FROM US PHASE I CLINICAL TRIAL OF ULTRA-RAPID ACTING INSULIN CANDIDATE AT247 DELIVERED VIA INSULIN PUMP AT ADA ANNUAL MEETING

- Data presented at the American Diabetes Association 83rd Scientific Sessions

- AT247 delivers significantly accelerated insulin absorption and early exposure (PK profile) compared with NovoLog® and Fiasp®

- Further supports potential to enable more effective disease management for people with Type I diabetes via fully automated closed loop insulin pump delivery (artificial pancreas)

Read more

Voting is now open for the BioNewsRound Award 2023 - Translational Research

 


VOTE NOW

Read more

An exciting time for innovation at Norwich Research Park

Discover how four seperate developments are making their mark in history at Norwich Research Park following a recent announcement from Anglia Innovation Partnership CEO, Roz Bird, at the 'Innovation in the East of England' event. Read more...


The news article shares insights into:

Read more

LBIC News Summer 2023

Check out the latest updates on LBIC's expansion, investment, seaweed and virtual tenancy offers in the latest LBIC Newsletter: https://www.lbic.com/lbic-newsletter


Read more

Pages